Rana, Nirmal Kumar

Duchenne muscular dystrophy (DMD) is a fatal muscle-wasting disease caused by the absence of a dystrophin protein. Elevating utrophin, a dystrophin paralogue, offers an alternative therapeutic strategy for treating DMD, irrespective of the mutation type. Herein, we report the design and synthesis of novel quinazoline and quinoline-based small molecules as potent utrophin modulators screened via high throughput In-Cell ELISA in C2C12 cells. Remarkably, lead molecule SG-02, identified from a library of 70 molecules, upregulates utrophin 2.7-fold at 800 nM in a dose-dependent manner, marking the highest upregulation within the nanomolar range. SG-02’s efficacy was further validated through DMD patient-derived cells, demonstrating a significant 2.3-fold utrophin expression. Mechanistically, SG-02 functions as an AhR antagonist, with excellent binding affinity (Kd = 41.68 nM). SG-02 also enhances myogenesis, as indicated by an increased MyHC expression. ADME evaluation supports SG-02’s oral bioavailability. Overall, SG-02 holds promise for addressing the global DMD population. © 2024 American Chemical Society.

Stereodivergent catalysis, the art of accessing multiple stereoisomers from the same starting materials, has been a keystone of modern organic chemistry. Among the numerous factors influencing stereoselectivity, the choice of solvent plays an important role for the formation of particular isomer. This review elucidates the profound impact of solvent properties on stereoselective outcomes in organic synthesis. By virtue of its unique physicochemical attributes, the solvent environment can exert diverse effects on reaction pathways, conformational preferences, and intermolecular interactions, ultimately dictating the stereochemical fate of the reactants. In particular, recent elegant examples of solvent-controlled stereodivergent reactions have been categorically highlighted with emphasis on mechanistic aspects as well as synthetic potential.

A simple and efficient approach to enantioenriched α,β-disubstituted γ-butyrolactones has been developed through multifunctional modular organocatalysis in a highly enantioselective (>99% ee) and diastereoselective (>30:1) manner following a one-pot sequential Michael-hemiacetalization-oxidation reaction. The catalytic process has great substrate compatibility, and the products have been transformed to synthetically useful molecules. The methodology has also been applied to the formal synthesis of (+)-Pilocarpine. ©

An efficient domino Michael-Michael reaction of ω- and δ-nitro α,β-unsaturated esters with alkylidenepyrazolones has been accomplished using DABCO as the organocatalyst under mild reaction conditions. Under the present organocatalytic method, a wide range of carbocyclic spiro-pyrazolones with three tertiary stereogenic centers and a quaternary stereocenter has been prepared in high yields and excellent diastereoselectivities. An ester and nitro groups present in the spiro-pyrazolones have been utilized for further structural transformations.